TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough bile duct cancer
Disease control CompletedThis study tested a three-drug combination for people with advanced bile duct cancer that worsened after standard chemotherapy. The treatment included chemo beads placed directly into the liver tumor, a targeted therapy pill (apatinib), and an immunotherapy drug (PD-1 antibody). …
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New pain combo eases suffering in liver cancer procedure
Symptom relief CompletedThis study looked at whether a combination of two pain medicines (hydromorphone and flurbiprofen) given through a vein could better control pain in 129 people with intermediate-to-advanced liver cancer undergoing a procedure called TACE. The goal was to reduce pain during and aft…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Symptom relief
Last updated Apr 29, 2026 15:02 UTC